TY - JOUR
T1 - Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI
AU - Gaw, Nathan
AU - Hawkins-Daarud, Andrea
AU - Hu, Leland S.
AU - Yoon, Hyunsoo
AU - Wang, Lujia
AU - Xu, Yanzhe
AU - Jackson, Pamela R.
AU - Singleton, Kyle W.
AU - Baxter, Leslie C.
AU - Eschbacher, Jennifer
AU - Gonzales, Ashlyn
AU - Nespodzany, Ashley
AU - Smith, Kris
AU - Nakaji, Peter
AU - Mitchell, J. Ross
AU - Wu, Teresa
AU - Swanson, Kristin R.
AU - Li, Jing
N1 - Funding Information:
We would like to acknowledge the funding received for this work from the National Institutes of Health (NS082609) (L.S.H.) (R01CA16437, R01NS060752, U54CA210180, U54CA143970, U54193489, U01CA220378) (K.R.S), the James S. McDonnell Foundation (K.R.S.) the Ben & Catherine Ivy Foundation (K.R.S.) and the Mayo Clinic Foundation (L.S.H.).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Glioblastoma (GBM) is a heterogeneous and lethal brain cancer. These tumors are followed using magnetic resonance imaging (MRI), which is unable to precisely identify tumor cell invasion, impairing effective surgery and radiation planning. We present a novel hybrid model, based on multiparametric intensities, which combines machine learning (ML) with a mechanistic model of tumor growth to provide spatially resolved tumor cell density predictions. The ML component is an imaging data-driven graph-based semi-supervised learning model and we use the Proliferation-Invasion (PI) mechanistic tumor growth model. We thus refer to the hybrid model as the ML-PI model. The hybrid model was trained using 82 image-localized biopsies from 18 primary GBM patients with pre-operative MRI using a leave-one-patient-out cross validation framework. A Relief algorithm was developed to quantify relative contributions from the data sources. The ML-PI model statistically significantly outperformed (p < 0.001) both individual models, ML and PI, achieving a mean absolute predicted error (MAPE) of 0.106 ± 0.125 versus 0.199 ± 0.186 (ML) and 0.227 ± 0.215 (PI), respectively. Associated Pearson correlation coefficients for ML-PI, ML, and PI were 0.838, 0.518, and 0.437, respectively. The Relief algorithm showed the PI model had the greatest contribution to the result, emphasizing the importance of the hybrid model in achieving the high accuracy.
AB - Glioblastoma (GBM) is a heterogeneous and lethal brain cancer. These tumors are followed using magnetic resonance imaging (MRI), which is unable to precisely identify tumor cell invasion, impairing effective surgery and radiation planning. We present a novel hybrid model, based on multiparametric intensities, which combines machine learning (ML) with a mechanistic model of tumor growth to provide spatially resolved tumor cell density predictions. The ML component is an imaging data-driven graph-based semi-supervised learning model and we use the Proliferation-Invasion (PI) mechanistic tumor growth model. We thus refer to the hybrid model as the ML-PI model. The hybrid model was trained using 82 image-localized biopsies from 18 primary GBM patients with pre-operative MRI using a leave-one-patient-out cross validation framework. A Relief algorithm was developed to quantify relative contributions from the data sources. The ML-PI model statistically significantly outperformed (p < 0.001) both individual models, ML and PI, achieving a mean absolute predicted error (MAPE) of 0.106 ± 0.125 versus 0.199 ± 0.186 (ML) and 0.227 ± 0.215 (PI), respectively. Associated Pearson correlation coefficients for ML-PI, ML, and PI were 0.838, 0.518, and 0.437, respectively. The Relief algorithm showed the PI model had the greatest contribution to the result, emphasizing the importance of the hybrid model in achieving the high accuracy.
UR - http://www.scopus.com/inward/record.url?scp=85068933002&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068933002&partnerID=8YFLogxK
U2 - 10.1038/s41598-019-46296-4
DO - 10.1038/s41598-019-46296-4
M3 - Article
C2 - 31296889
AN - SCOPUS:85068933002
SN - 2045-2322
VL - 9
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 10063
ER -